Crosstalk network among multiple inflammatory mediators in liver fibrosis

doi:10.3748/wjg.v25.i33.4835

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12438)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

1205

WORD

319

HTML

8344

Figures (1-4)

388

Tables (1-1)

228

Sum=10484

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

790

Download

1164

Sum=1954

Sep 7, 2019 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (46)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 7, 2019; 25(33): 4835-4849
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4835

Full Size Figure Download Figure

Figure 2 Toll-like receptor mediated crosstalk network in liver fibrosis. Toll-like receptor is a member of DAMPs that recognize pathogen-associated molecules and thereby transmit inflammatory signals that cause inflammatory responses. TLR: Toll-like receptor; MAPK: Mitogen-activated protein kinase; NF-кB: Nuclear factor-кB; HSC: Hepatic stellate cell; DC: Dendritic cells; NK: Natural killer.

Citation: Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849
URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4835.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i33.4835